(Q34446661)

English

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Martin Schrappe

10

object named as

Martin Schrappe

1 reference

Europe PubMed Central

2 August 2017

Thomas Klingebiel

7

object named as

Thomas Klingebiel

1 reference

Europe PubMed Central

2 August 2017

author name string

Frank Berthold

1

1 reference

Europe PubMed Central

2 August 2017

Joachim Boos

2

1 reference

Europe PubMed Central

2 August 2017

Stefan Burdach

3

1 reference

Europe PubMed Central

2 August 2017

Rudolf Erttmann

4

1 reference

Europe PubMed Central

2 August 2017

Günter Henze

5

1 reference

Europe PubMed Central

2 August 2017

Johann Hermann

6

1 reference

Europe PubMed Central

2 August 2017

Bernhard Kremens

8

1 reference

Europe PubMed Central

2 August 2017

Freimut H Schilling

9

1 reference

Europe PubMed Central

2 August 2017

Thorsten Simon

11

1 reference

Europe PubMed Central

2 August 2017

Barbara Hero

12

1 reference

Europe PubMed Central

2 August 2017

publication date

1 September 2005

1 reference

Europe PubMed Central

2 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

2 August 2017

6

1 reference

Europe PubMed Central

2 August 2017

649-658

1 reference

Europe PubMed Central

2 August 2017

9

1 reference

Europe PubMed Central

2 August 2017

The role of autologous bone marrow transplantation in advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

"Megatherapy" for advanced neuroblastoma--rationale and role.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of myeloablative therapy in improved outcome for high risk neuroblastoma: review of recent Children's Cancer Group results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stage IV neuroblastoma in patients over 1 year of age at diagnosis: consolidation of poor responders with combined busulfan, cyclophosphamide and melphalan followed by in vitro mafosfamide-purged autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuroblastoma: current drug therapy recommendations as part of the total treatment approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of radiotherapy for high-risk neuroblastoma: a Children’s Cancer Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970291-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(05)70291-6

1 reference

Europe PubMed Central

2 August 2017

release_zsdmcnylebdmvbs63q2y2aquhq

1 reference

https://api.fatcat.wiki/v0/release/zsdmcnylebdmvbs63q2y2aquhq

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34446661&oldid=1838423348"